Country Readiness for COVID-19 Vaccines

This article is part six in a series of explainers on vaccine development and distribution and was originally published on the World Health Organization’s website. Below is an excerpt. 

Countries are beginning to deploy COVID-19 vaccines, bringing new hope to the fight against the global pandemic. WHOUNICEFGavi and many other partners are working together to support countries in preparing for COVID-19 vaccine introduction. They have provided a COVID-19 vaccine introduction toolbox that has all the resources a country needs to get ready for delivering COVID-19 vaccines. Within this toolbox, training is available for national/subnational focal points and health workers to equip them with the necessary knowledge and skills.

What is the process for countries to get COVID-19 vaccines from the COVAX Facility?

A total of 92 low- and middle-income economies will be able to access COVID-19 vaccines through the COVAX Facility Advance Market Commitment (AMC).

These AMC 92 countries must develop a COVID-19 National Deployment and Vaccination Plans (NDVPs) which is reviewed by WHO, UNICEF and other partners to help the country be sure the plan is as good as it can be. NDVPs can be submitted through the Partners Platform.

Once a country’s NDVP is reviewed to ensure the key readiness criteria are met, they can be allocated vaccines through the COVAX Facility. Non-AMC countries are also welcome to submit their NDVP for review and receive feedback to strengthen their plan.

What is a National Deployment and Vaccination Plan?

A National Deployment and Vaccination Plan is an operational plan to implement and monitor COVID-19 vaccination rollout in a country. The NDVP serves as the “one-country plan” and main framework for a country’s vaccine introduction and vaccination efforts.

Why should countries develop a National Deployment and Vaccination Plan?

Developing an NDVP helps countries prepare for COVID-19 vaccination, identify resource needs and streamline the process for introducing vaccines. Once an NDVP is developed, countries work on its implementation, including the detailed planning of  vaccine delivery strategies, logistics, HR and funding mobilization.

How will country readiness be assessed?

A review process has been set up to provide support and feedback to countries for improving and finalizing their plans. This ensures that a country’s NDVP includes the necessary elements to rapidly deploy vaccines and implement COVID-19 vaccination, and that any recommendations for improvement are addressed.

Once an AMC 92 participant submits its NDVP, a Regional Review Committee (RRC) assesses the plan and evaluates country preparedness and capacity for vaccine allocation, deployment and administration. Those participants with an NDVP that meets the standardized readiness assessment join the process for allocating COVID-19 vaccines from the COVAX Facility. Countries should take into account the recommendations from the review to further improve their preparedness for vaccine introduction.

Read the full article here.

You May Also Like

Delivering 270M+ COVID-19 vaccines at just $0.29 per dose: The Bangladesh experience

Bangladesh launched its COVID-19 vaccination program in February 2021 with the ambitious aim of reaching 80% of the population with two doses. The program used a phased approach, initially targeting priority groups, and expanding eligibility over time as supply ramped up. By June 2022, the country had achieved its goal—having delivered over 270 million COVID-19 … Read More

New evidence on the costing the delivery of COVID-19 vaccines in Mozambique and the Philippines

ThinkWell has released two new reports on the cost of delivering COVID-19 vaccines in Mozambique and the Philippines, aiming to support governments and address the knowledge gap on the cost of these vaccination programs. In partnership with the Universidade Eduardo Mondlane and Ateneo de Manila University, ThinkWell conducted retrospective, bottom-up costing studies, as well as … Read More

📣 Lessons from Moldova on the Use of Pharmacists to Increase Demand for COVID-19 Vaccinations

When the COVID-19 vaccines first launched in Moldova, vaccine confidence across the country was low, particularly among target populations. To combat this, Moldova launched a national campaign using pharmacists to increase awareness, confidence, and coverage of the vaccines. Linked recently sat down with Oxana Constantinova, Doctor Epidemiologist, Center for Public Health, Moldova, to understand the … Read More